Psyence Biomedical Ltd.
PBM
$5.21
-$0.445-7.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -974.40K | -974.40K | 1.48M | 1.48M | -24.78M |
| Total Depreciation and Amortization | 1.20K | 1.20K | 900.00 | 900.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.10K | 150.10K | -2.33M | -2.33M | 24.71M |
| Change in Net Operating Assets | -286.10K | -286.10K | 93.00K | 93.00K | -613.20K |
| Cash from Operations | -1.11M | -1.11M | -757.90K | -757.90K | -678.60K |
| Capital Expenditure | -1.70K | -1.70K | -3.20K | -3.20K | -2.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.20K | -3.20K | -- | -- | -- |
| Cash from Investing | -4.90K | -4.90K | -3.20K | -3.20K | -2.90K |
| Total Debt Issued | 0.00 | 0.00 | 500.00K | 500.00K | 892.50K |
| Total Debt Repaid | -- | -- | -- | -- | -75.00K |
| Issuance of Common Stock | 10.20K | 10.20K | 860.80K | 860.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.21M | 3.21M | -- | -- | -72.20K |
| Cash from Financing | 3.22M | 3.22M | 1.36M | 1.36M | 745.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.10M | 2.10M | 599.70K | 599.70K | 63.90K |